Catalyst Wire Dossier Catalyst Wire Dossier

Clazosentan

clazosentan · Idorsia Pharmaceuticals Ltd.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Clazosentan, covering 2018-07-09 to 2024-01-10. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Research Study With Clazosentan to Evaluate Its Effects on Preventing Complications Due to the Narrowing of the Blood Vessels (Vasospasm) in the Brain, Caused by Bleeding Onto the Surface of the Brain [Phase 3]

See pricing